X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 16/Sep 22:24

FDA Approves Tremfya for Ulcerative Colitis

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.Tremfya is the first and only dual-acting interleukin-23 inhibitor...

Articles similaires

Sorry! Image not available at this time

Monthly News Roundup - October 2024

drugs.com - 31/Oct 00:10

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

Sorry! Image not available at this time

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

drugs.com - 25/Oct 21:10

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

Sorry! Image not available at this time

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea

drugs.com - 04/Nov 00:11

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

Sorry! Image not available at this time

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

drugs.com - 31/Oct 21:10

THE WOODLANDS, Texas, October 31, 2024 -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug...

Sorry! Image not available at this time

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Sorry! Image not available at this time

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

drugs.com - 29/Oct 22:10

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics...

Sorry! Image not available at this time

PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission

drugs.com - 30/Oct 05:10

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

P53 Mutation: A Key Player in Cancer Risk for Ulcerative Colitis Patients

medindia.net - 28/Oct 21:13

Research has uncovered the role of the p53 gene in ulcerative colitis, suggesting a potential new drug target to prevent disease progression to...

Sorry! Image not available at this time

What You Need to Know About FluMist, the Nasal Flu Vaccine

drugs.com - 26/Oct 13:00

SATURDAY, Oct. 26, 2024 -- Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you...

Les derniers communiqués